Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lee Stuart Cohen, M.D.

Co-Author

This page shows the publications co-authored by Lee Cohen and Hadine Joffe.
Connection Strength

7.594
  1. Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. J Clin Endocrinol Metab. 2016 10; 101(10):3847-3855.
    View in: PubMed
    Score: 0.699
  2. Concern about the use of venlafaxine to treat vasomotor symptoms--reply. JAMA Intern Med. 2015 Apr; 175(4):658-9.
    View in: PubMed
    Score: 0.631
  3. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med. 2014 Jul; 174(7):1058-66.
    View in: PubMed
    Score: 0.599
  4. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab. 2011 Jul; 96(7):E1044-54.
    View in: PubMed
    Score: 0.480
  5. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol. 2010 Feb; 202(2):171.e1-171.e11.
    View in: PubMed
    Score: 0.438
  6. Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report. J Clin Psychiatry. 2007 Dec; 68(12):1954-62.
    View in: PubMed
    Score: 0.379
  7. Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry. 2007 Jun; 68(6):943-50.
    View in: PubMed
    Score: 0.366
  8. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry. 2006 Feb; 67(2):297-304.
    View in: PubMed
    Score: 0.334
  9. Diagnosis and management of mood disorders during the menopausal transition. Am J Med. 2005 Dec 19; 118 Suppl 12B:93-7.
    View in: PubMed
    Score: 0.331
  10. Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr Clin North Am. 2003 Sep; 26(3):563-80.
    View in: PubMed
    Score: 0.283
  11. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause. 2002 Nov-Dec; 9(6):392-8.
    View in: PubMed
    Score: 0.267
  12. Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms. J Clin Endocrinol Metab. 2020 03 01; 105(3).
    View in: PubMed
    Score: 0.222
  13. Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo. J Clin Psychopharmacol. 2017 Oct; 37(5):609-614.
    View in: PubMed
    Score: 0.187
  14. Armodafinil for fatigue associated with menopause: an open-label trial. Menopause. 2016 Feb; 23(2):209-14.
    View in: PubMed
    Score: 0.167
  15. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause. 2014 Apr; 21(4):347-54.
    View in: PubMed
    Score: 0.147
  16. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas. 2013 Jun; 75(2):170-4.
    View in: PubMed
    Score: 0.138
  17. Disparate rates of new-onset depression during the menopausal transition in 2 community-based populations: real, or really wrong? Am J Epidemiol. 2013 May 15; 177(10):1148-56.
    View in: PubMed
    Score: 0.138
  18. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network. Menopause. 2013 Mar; 20(3):261-8.
    View in: PubMed
    Score: 0.136
  19. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause. 2011 Mar; 18(3):279-84.
    View in: PubMed
    Score: 0.119
  20. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause. 2009 Jul-Aug; 16(4):671-9.
    View in: PubMed
    Score: 0.106
  21. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. Am J Med. 2008 Feb; 121(2):159-162.e1.
    View in: PubMed
    Score: 0.096
  22. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol. 2006 Dec; 108(6):1402-10.
    View in: PubMed
    Score: 0.088
  23. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause. 2006 Sep-Oct; 13(5):780-6.
    View in: PubMed
    Score: 0.087
  24. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biol Psychiatry. 2006 Dec 15; 60(12):1378-81.
    View in: PubMed
    Score: 0.087
  25. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006 May-Jun; 13(3):411-22.
    View in: PubMed
    Score: 0.085
  26. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006 Jun 01; 59(11):1078-86.
    View in: PubMed
    Score: 0.084
  27. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005 Oct; 7(5):465-70.
    View in: PubMed
    Score: 0.082
  28. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol. 2003 Dec; 189(6):1523-30.
    View in: PubMed
    Score: 0.072
  29. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Harv Rev Psychiatry. 2003 Mar-Apr; 11(2):99-108.
    View in: PubMed
    Score: 0.068
  30. Lights on MsFLASH: a review of contributions. Menopause. 2020 04; 27(4):473-484.
    View in: PubMed
    Score: 0.056
  31. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018 10; 25(10):1069-1085.
    View in: PubMed
    Score: 0.050
  32. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. J Womens Health (Larchmt). 2019 02; 28(2):117-134.
    View in: PubMed
    Score: 0.050
  33. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause. 2018 05; 25(5):500-507.
    View in: PubMed
    Score: 0.049
  34. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause. 2017 Oct; 24(10):1160-1166.
    View in: PubMed
    Score: 0.047
  35. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 01; 176(7):913-20.
    View in: PubMed
    Score: 0.043
  36. Symptom clusters among MsFLASH clinical trial participants. Menopause. 2016 Feb; 23(2):158-65.
    View in: PubMed
    Score: 0.042
  37. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol. 2015 Aug; 126(2):413-422.
    View in: PubMed
    Score: 0.040
  38. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause. 2015 Jun; 22(6):607-15.
    View in: PubMed
    Score: 0.040
  39. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstet Gynecol. 2014 Aug; 124(2 Pt 1):233-241.
    View in: PubMed
    Score: 0.038
  40. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014 Apr; 21(4):330-8.
    View in: PubMed
    Score: 0.037
  41. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause. 2014 Apr; 21(4):339-46.
    View in: PubMed
    Score: 0.037
  42. Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
    View in: PubMed
    Score: 0.036
  43. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol. 2014 Mar; 210(3):244.e1-11.
    View in: PubMed
    Score: 0.036
  44. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas. 2012 Dec; 73(4):361-8.
    View in: PubMed
    Score: 0.033
  45. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011 Jan 19; 305(3):267-74.
    View in: PubMed
    Score: 0.029
  46. Efficacy of 17beta-estradiol on depression: is estrogen deficiency really necessary? J Clin Psychiatry. 2002 May; 63(5):451; author reply 451-2.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.